DSDiana Sitenda

Diana Sitenda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Diana Sitenda has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Adjunct Diagnostic Accuracy of Antigen-specific Interleukin-2 for Latent Tuberculosis Infection in Pregnancy

    by Felix Bongomin, Phillip Ssekamatte, Ronald Olum, Diana Sitenda, Davis Kibirige, Joseph Baruch Baluku, Stephen Cose, Irene Andia-Biraro

    Background: Pregnancy modulates immune responses against Mycobacterium tuberculosis (Mtb) infection. Cytokines, including interleukin-2 (IL-2), play a crucial role in Mtb containment, mainly by inducing the proliferation of T cells. However, the role of IL-2 in latent tuberculosis (TB) infection (LTBI) screening has not been completely explored. We, therefore, evaluated the diagnostic accuracy and optimal cutoff value (OCV) of IL-2 as a potential adjunct biomarker for screening LTBI during pregnancy. Methods: We enrolled pregnant women without previous active TB at Kawempe National Referral Hospital, Uganda, in 2020. We tested for LTBI using the QuantiFERON-TB Gold-Plus assay. Blood in quantiFERON blood collection tubes was stimulated with Mtb peptides of ESAT-6 and CFP-10 and following incubation, IL-2 culture supernatant levels were measured in an 11-plex Luminex assay using the Luminex® 100/200™ System with xPONENT® 3.1 software. LTBI positivity was defined as an IFN-γ concentration ≥0.35 IU/mL (calculated as TB1/TB2-Nil). A receiver operator characteristic curve was plotted to assess the diagnostic performance of Mtb-specific IL-2 culture supernatants using STATA 18.0. The OCV was determined using the Youden index, considering sensitivity and specificity. Results: Of 159 participants, the median gestational age was 26.1 (IQR: 20.0–31.6) weeks, 8.2% (n = 13) had HIV, and 10.1% (n = 16) were recent TB contacts. Overall, 79 (49.7%) had LTBI. Mtb-specific IL-2 levels were significantly higher in LTBI than in the non-LTBI group (847.9 (418.2–1309.1) versus 147.73 (100.38–207.19) pg/mL, P < .001). IL-2 achieved an AUC of 0.88 (95% CI: 0.82–0.93), with 76% sensitivity and 96% specificity. IFN-γ showed an AUC of 0.83 (95% CI: 0.76–0.90), with 78% sensitivity and 90% specificity. The combined IL-2 + IFN-γ response yielded the highest accuracy, with an AUC of 0.89 (95% CI: 0.83–0.94), 77% sensitivity, and 95% specificity. Conclusions: Mtb-specific IL-2 culture supernatant levels showed good discriminatory power for LTBI detection in pregnancy, comparable to IFN-γ, with the combined IL-2+ IFN-γ response yielding the highest accuracy. These findings support the potential utility of IL-2, alone or with IFN-γ, as an adjunct biomarker for LTBI screening in pregnant women, warranting further validation in larger, diverse cohorts.


  • Open Access

    Bacille Calmette-Guérin-specific IgG titres among infants born to mothers with active tuberculosis disease in Uganda

    by Diana Sitenda, Phillip Ssekamatte, Rose Nakavuma, Andrew Peter Kyazze, Felix Bongomin, Joseph Baruch Baluku, Rose Nabatanzi, Davis Kibirige, Robert J. Wilkinson, Annettee Nakimuli, et al.

    Infants born to mothers with active tuberculosis disease (ATB) are at risk of poor clinical outcomes such as low birth weight and perinatal mortality. However, little is known about the influence of maternal ATB exposure on their vaccine responses during infancy. The study explored how maternal ATB affects infants’ vaccine responses, hypothesising reduced responses to Bacille Calmette-Guérin (BCG) and other infant vaccines. This was a case-control study with a longitudinal component of infants born to mothers with bacteriologically confirmed ATB (cases) and infants born to mothers without ATB (controls) carried out between September 2021 and June 2022. Quantitative BCG, diphtheria, tetanus, and measles-specific IgG ELISA assays were performed on infant plasma harvested from lithium-heparin blood collected on first encounter after birth (0), at 3, 6, and 9 months. We used prism v10.1.2, mixed-effects modelling, and Tukey’s multiple comparison testing to determine mean differences (MD) between the cases and controls at all time points. Exposed infant cases had reduced IgG titres to BCG at baseline compared to the controls (p = 0.032), with a mean of 125.8 vs. 141.1 IU/mL, respectively. This difference was, however, not sustained at the other time points. Similarly, we demonstrated trends towards reduced responses to tetanus, diphtheria, and measles vaccines among infant cases at baseline and three months. However, the trend was not sustained at months six and nine. The mean titres for tetanus at baseline and 3 months for cases versus controls are 1.744 vs. 2.917 IU/mL (p < 0.0001) and 1.716 vs. 2.344 IU/mL (p = 0.018), respectively. The mean titres for diphtheria at 3 months for cases versus controls were 0.022 vs. 0.075 IU/mL (p = 0.006), respectively. We have demonstrated that maternal TB disease influences vaccine responses to BCG and other infant vaccines. This has implications for increased risk of childhood TB and other preventable diseases. Not applicable.


  • Open Access

    Mycobacterium tuberculosis -specific cytokine responses of infants born to mothers with active tuberculosis in Uganda

    by Diana Sitenda, Phillip Ssekamatte, Rose Nakavuma, Andrew Peter Kyazze, Felix Bongomin, Joseph Baluku, Rose Nabatanzi, Davis Kibirige, Stephen Cose, Irene Andia-Biraro, et al.

    Background: Immunizing infants with various vaccines, including Bacillus Calmette–Guérin (BCG), Diphtheria-Pertusis-Tetanus (DPT), and measles, aims to enhance immunity. In instances where vaccine responses have been reported to be compromised, individuals are prone to infection. The BCG vaccine, for example, induces strong type 1 immune responses, particularly interferon-gamma (IFN-γ) expression, that are essential for protection against Mycobacterium tuberculosis ( Mtb) . However, there is scanty evidence on whether this effect is established or sustained when infants are exposed to Mtb either in utero or after birth. We compared TB-specific cytokine responses for IFN-γ, interleukin (IL)-2 (IL-2), tumour necrosis factor-alpha (TNF-α), IL-17A, and Granulocyte-macrophage colony-stimulating factor (GM-CSF) using supernatants harvested from QFT-Plus Blood Collection Tubes. Methods: This cross-sectional study compared 22 infants born to mothers with bacteriologically confirmed active tuberculosis (TB), defined as TB exposed or cases, to 20 infants born to mothers without active TB, defined as TB non-exposed or controls. Plasma harvested from the QFT-plus tubes (TB1 and TB2) was used to perform a 5-plex Luminex assay using the LX 100/200 Luminex machine and measured in pg/mL. Data was analysed using R (v.4.4.1). The Mann-Whitney U test was used to determine statistical significance at a p-value less than 0.05 and a 95% confidence interval. Data was expressed as median and interquartile ranges (IQR). Results: TB-exposed infants showed IFNγ responses were slightly higher among TB-exposed infants compared to non-exposed (Medians (IQR): 15.49 (14.58-16.49) versus 14.96 (14.60-16.60), p=0.68, respectively. There was a strong expression of total IL-17A among TB-exposed compared to non-exposed 11.91 (10.89-13.50) versus 10.69 (10.17-11.64), p=0.035. We observed no differences in IL-2, TNF, and GM-CSF responses. Conclusion: TB exposure among infants slightly alters their Mtb -specific cytokine responses, especially IL-17A cytokine responses. This suggests possible ongoing Mtb infection among TB-exposed infants. Follow-up studies of such infants are necessary to assess their risk of future TB infection and disease and the potential need for TB chemoprophylaxis.

  • Open Access

    Reduced Bacille Calmette-Guérin -specific IgG titres among babies born to mothers with Active Tuberculosis Disease in Uganda

    by Diana Sitenda, Phillip Ssekamatte, Rose Nakavuma, Andrew Peter Kyazze, Felix Bongomin, Joseph Baluku, Rose Nabatanzi, Davis Kibirige, Annette Nakimuli, Stephen Cose, et al.

    Background Babies born to mothers with active tuberculosis disease (ATB) are at risk of poor clinical outcomes such as low birth weight and perinatal mortality. However, little is known about the influence of maternal ATB exposure on their vaccine responses during infancy. The study aimed to explore how maternal ATB affects infants’ vaccine responses, hypothesising reduced responses to BCG and other infant vaccines. Methods This was a case-control study with a longitudinal component of babies born to mothers with bacteriologically confirmed ATB (cases) and babies born to mothers without ATB (controls) carried out between September 2021 and June 2022. Quantitative BCG, diphtheria, tetanus, and measles-specific IgG ELISA assays were performed on infant plasma harvested from lithium-heparin blood collected on first encounter after birth (0), at 3, 6, and 9 months. We used prism v10.1.2, Mixed-effects modelling, and Tukey’s multiple comparison testing to determine mean differences (MD) between the cases and controls at all time points. Results Infants cases had reduced IgG titres to BCG at baseline compared to the controls (p=0.04), with a mean of 125.8/141.1 IU/mL, respectively. This difference was, however, not sustained at the other time points. Similarly, we demonstrated strong trends of reduced responses to tetanus, diphtheria, and measles vaccines among infant cases at baseline and three-month time points and weakly at months six and nine. The mean titres for tetanus at baseline and 3 months for cases versus controls are 1.744/2.917 IU/mL and 1.716/2.344 IU/mL (pConclusion We have demonstrated that maternal TB disease influences vaccine responses to BCG and other infant vaccines. This has implications for increased risk of childhood TB and other preventable diseases.

  • Open Access

    Traditional uses and anti-bacterial activity of Opuntia ficus-indica stem and fruit extracts in Kasese District, Western- Uganda

    by Diana Sitenda, Godwin Anywar, Esezah K. Kakudidi

    Opuntia ficus-indica (OFI), also known as prickly pear, has been used in traditional medicine. This is attributed to its medicinal properties that contribute to treatment of conditions including asthma, stomach ulceration, and diabetes. We carried out a cross-sectional study in 2018 in Kasese district, western Uganda, to determine the traditional uses of O. ficus-indica and the anti-bacterial activity of the stem and fruit extracts of the plant. We interviewed participants using questionnaires and obtained data for traditional uses. We also performed the Agar well diffusion test to measure the anti-bacterial activity of the fruit and stem extracts of OFI. Data was analysed using SPSS version 26.0, and a P value of less than 0.05 was considered statistically significant after performing the one-way ANOVA test. Out of the 56 respondents, results showed that all (100%) of the respondents used prickly pear as food, 90% as ornamental, 80% as an anti-ulcer, 60% as an anti-constipation herb, and 20% used the plant to cleanse the body. On the other hand, fruit and stem extracts exhibited anti-bacterial activity as determined by the diameters of inhibition zones: 27mm and 21mm, respectively, compared to ampicillin (28mm), which was our positive control. The fruit extracts showed a higher anti-bacterial activity against E. coli bacteria than the stem extract (p<0.05), hence the rejection of the null hypothesis, which stated that there is no significant variation in the anti-bacterial activity of Opuntia ficus-indicaextracts from the stem and fruit.


  • Open Access

    Traditional uses and anti-bacterial activity of Opuntia ficus-indica stem and fruit extracts in Kasese District, Western- Uganda

    by Diana Sitenda, Godwin Anywar, Esezah Kyomugisha Kakudidi

    Opuntia ficus-indica (OFI), also known as prickly pear has been used in traditional folk medicine. This is due to its medicinal properties that contribute to treatment of conditions including asthma, stomach ulceration, and diabetes. We carried out a cross-sectional study in 2018 in Kasese district, western Uganda to determine the traditional uses of O. ficus-indica and the anti-bacterial activity of the stem and fruit extracts of the plant. We interviewed participants using questionnaires and obtained data for the traditional uses. We also used the Agar well diffusion method to measure the antibacterial activity of the fruit and stem extracts of OFI. Data was analysed using SPSS version226.0 and a P value less than 0.05 was considered statistically significant after performing the one-way ANOVA test. Out of the 56 respondents, results showed that all (100%) of the respondents used prickly pear as food, 90% as ornamental, 80% as anti-ulcer, 60% as anti-constipation herb and 20% use the plant to cleanse the body. On the other hand, both fruit and stem extracts exhibited anti-bacterial activity as determined by the diameters of zones of inhibition: 27mm and 21mm respectively, compared to ampicillin (28mm) which was our positive control. The fruit extracts showed a higher anti-bacterial activity against E. coli bacteria than the stem extract (p<0.05) hence the rejection of the null hypothesis which stated that there is no significant variation in the anti-bacterial activity of Opuntia ficus-indica extracts from the stem and fruit.